Novel drugs — some old, some new — may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure.
Novel drugs — some old, some new — may offer patients fresh ways to reduce their heart risks beyond the usual medicines that lower cholesterol and blood pressure.
One new study found that heart attack survivors benefited from a medicine long used to treat gout. Several experimental drugs also showed early promise for interfering with heart-harmful genes while leaving the genes themselves intact.that wrapped up Monday in Philadelphia. “There’s a lot of excitement” about the new gene-targeting medicines, especially because they seem to last so long, saidScientists have been exploring gene therapy to attack the root cause of many diseases by altering a patient’s DNA. The new drugs essentially accomplish the same thing without tampering with genes, said, a doctor who studies the genetics of cardiovascular disease at the University of Pennsylvania’s Perelman School of Medicine.
The medicines work by silencing or blocking messages that genes give to cells to make proteins that can do harm. For example, they can hinder cells’ ability to allow cholesterol to accumulate. The first few of theseFurthest along is
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
'Downton Abbey' Producer Adapting 'Daredevil' Writer Charles Soule's Novel 'Anyone'Carnival Films, the NBCUniversal-owned banner behind DowntonAbbey, has acquired the rights to Anyone, the second novel by CharlesSoule, the New York Times-bestselling comic book author known for writing the likes of Daredevil and She-Hulk.
Baca lebih lajut »
The Ms. Q&A: The Black, Feminist Subtext of Melanie S. Hatter's Award-Winning Novel 'Malawi's Sisters'.karlajstrand spoke with author Melanie S. Hatter about her latest book, 'Malawi’s Sisters,' a powerful story of an African American family dealing with racial violence that threatens to tear them apart.
Baca lebih lajut »
Study casts doubt on need for many heart proceduresIn patients with severe but stable heart disease, a procedure to improve blood flow may reduce chest pain but not the risk of heart attack or death.
Baca lebih lajut »
FDA Approves Crizanlizumab: Here Is A New Drug For Sickle Cell DiseaseNovartis will have the go-ahead to begin marketing Adakveo, the first targeted therapy for sickle cell disease.
Baca lebih lajut »
For heart disease, meds may work as well as invasive surgery, major trial showsHigh-risk patients with stable heart disease may fare just as well on medications alone, versus having invasive heart operations such as stents and bypass surgeries, according to a major trial. The results were presented Saturday at the American Heart Association's yearly conference.
Baca lebih lajut »
White House urgently ramps up push for drug cost legislationBattling impeachment, White House presses for drug cost legislation with new urgency.
Baca lebih lajut »